Dr. Reddy's Laboratories Limited (FRA:RDDA)

Dr. Reddy's Laboratories Statistics

Total Valuation

FRA:RDDA has a market cap or net worth of EUR 10.07 billion. The enterprise value is 10.00 billion.

Market Cap	10.07B
Enterprise Value	10.00B

Important Dates

The next estimated earnings date is Monday, January 26, 2026.

Earnings Date	Jan 26, 2026
Ex-Dividend Date	Jul 25, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.03%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	26.81%
Owned by Institutions (%)	66.24%
Float	591.54M

Valuation Ratios

The trailing PE ratio is 17.91 and the forward PE ratio is 21.26.

PE Ratio	17.91
Forward PE	21.26
PS Ratio	3.07
PB Ratio	2.90
P/TBV Ratio	4.28
P/FCF Ratio	32.93
P/OCF Ratio	17.85
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.56, with an EV/FCF ratio of 32.69.

EV / Earnings	17.78
EV / Sales	3.04
EV / EBITDA	11.56
EV / EBIT	14.67
EV / FCF	32.69

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.16.

Current Ratio	1.85
Quick Ratio	1.13
Debt / Equity	0.16
Debt / EBITDA	0.65
Debt / FCF	1.84
Interest Coverage	22.06

Financial Efficiency

Return on equity (ROE) is 17.36% and return on invested capital (ROIC) is 11.37%.

Return on Equity (ROE)	17.36%
Return on Assets (ROA)	8.78%
Return on Invested Capital (ROIC)	11.37%
Return on Capital Employed (ROCE)	18.11%
Revenue Per Employee	118,037
Profits Per Employee	20,223
Employee Count	27,811
Asset Turnover	0.68
Inventory Turnover	2.02

Taxes

In the past 12 months, FRA:RDDA has paid 171.92 million in taxes.

Income Tax	171.92M
Effective Tax Rate	23.52%

Stock Price Statistics

The stock price has decreased by -11.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-11.85%
50-Day Moving Average	11.96
200-Day Moving Average	12.23
Relative Strength Index (RSI)	50.08
Average Volume (20 Days)	280

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:RDDA had revenue of EUR 3.28 billion and earned 562.43 million in profits. Earnings per share was 0.67.

Revenue	3.28B
Gross Profit	1.85B
Operating Income	679.58M
Pretax Income	731.03M
Net Income	562.43M
EBITDA	850.74M
EBIT	679.58M
Earnings Per Share (EPS)	0.67

Balance Sheet

The company has 669.81 million in cash and 561.65 million in debt, giving a net cash position of 108.16 million.

Cash & Cash Equivalents	669.81M
Total Debt	561.65M
Net Cash	108.16M
Net Cash Per Share	n/a
Equity (Book Value)	3.47B
Book Value Per Share	4.13
Working Capital	1.23B

Cash Flow

In the last 12 months, operating cash flow was 564.33 million and capital expenditures -258.49 million, giving a free cash flow of 305.83 million.

Operating Cash Flow	564.33M
Capital Expenditures	-258.49M
Free Cash Flow	305.83M
FCF Per Share	n/a

Margins

Gross margin is 56.43%, with operating and profit margins of 20.70% and 17.13%.

Gross Margin	56.43%
Operating Margin	20.70%
Pretax Margin	22.27%
Profit Margin	17.13%
EBITDA Margin	25.92%
EBIT Margin	20.70%
FCF Margin	9.32%

Dividends & Yields

This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 0.51%.

Dividend Per Share	0.06
Dividend Yield	0.51%
Dividend Growth (YoY)	-18.68%
Years of Dividend Growth	3
Payout Ratio	11.36%
Buyback Yield	0.03%
Shareholder Yield	0.54%
Earnings Yield	5.58%
FCF Yield	3.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 5, 2024. It was a forward split with a ratio of 5.

Last Split Date	Nov 5, 2024
Split Type	Forward
Split Ratio	5

Scores

FRA:RDDA has an Altman Z-Score of 5.69 and a Piotroski F-Score of 4.

Altman Z-Score	5.69
Piotroski F-Score	4